AMGEN INC Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Amgen Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • Amgen Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $271M, a 24.9% increase year-over-year.
  • Amgen Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $449M, a 62.1% decline year-over-year.
  • Amgen Inc annual Income Tax Expense (Benefit) for 2023 was $1.14B, a 43.3% increase from 2022.
  • Amgen Inc annual Income Tax Expense (Benefit) for 2022 was $794M, a 1.73% decline from 2021.
  • Amgen Inc annual Income Tax Expense (Benefit) for 2021 was $808M, a 7.02% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $449M $271M +$54M +24.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $395M $48M -$187M -79.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $582M $45M -$556M -92.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $1.14B $85M -$47M -35.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q3 2023 $1.19B $217M -$32M -12.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $1.22B $235M +$21M +9.81% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $1.2B $601M +$402M +202% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $794M $132M -$100M -43.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $894M $249M -$22M -8.12% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $916M $214M +$120M +128% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $796M $199M -$12M -5.69% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $808M $232M -$30M -11.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 $838M $271M +$86M +46.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $752M $94M -$133M -58.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $885M $211M +$16M +8.21% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $869M $262M -$18M -6.43% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-09
Q3 2020 $887M $185M -$124M -40.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $1.01B $227M -$158M -41% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $1.17B $195M -$127M -39.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 $1.3B $280M +$23M +8.95% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-16
Q3 2019 $1.27B $309M +$74M +31.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $1.2B $385M +$34M +9.69% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $1.17B $322M +$14M +4.55% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $1.15B $257M -$6.22B -96% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-09
Q3 2018 $7.37B $235M -$125M -34.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $7.5B $351M -$40M -10.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $7.54B $308M -$81M -20.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $7.62B $6.48B +$6.13B +1761% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-12
Q3 2017 $1.49B $360M -$41M -10.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $1.53B $391M +$57M +17.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-27
Q1 2017 $1.47B $389M +$31M +8.66% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-25
Q4 2016 $1.44B $348M +$235M +208% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-13
Q3 2016 $1.21B $401M +$72M +21.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-26
Q2 2016 $1.13B $334M -$10M -2.91% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-26
Q1 2016 $1.14B $358M +$105M +41.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-27
Q4 2015 $1.04B $113M +$121M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-13
Q3 2015 $918M $329M +$236M +254% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $682M $344M +$133M +63% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 $549M $253M +$122M +93.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $427M -$8M -$1M -14.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-14
Q3 2014 $428M $93M -$42M -31.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $470M $211M +$64M +43.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $406M $131M +$222M Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-27
Q4 2013 $184M -$7M -$142M -105% Oct 1, 2013 Dec 31, 2013 8-K 2016-10-31
Q3 2013 $326M $135M -$21M -13.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-29
Q2 2013 $347M $147M -$44M -23% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $391M -$91M -$273M -150% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-30
Q4 2012 $664M $135M +$18M +15.4% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-19
Q3 2012 $646M $156M +$156M Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-29
Q2 2012 $490M $191M +$22M +13% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $468M $182M +$1M +0.55% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 $467M $117M +$140M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-24
Q3 2011 $327M $0 -$198M -100% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $525M $169M -$93M -35.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 $618M $181M -$72M -28.5% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q4 2010 $690M -$23M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-27
Q3 2010 $198M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $262M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 $253M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.